| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10968375 | Vaccine | 2012 | 7 Pages |
Abstract
⺠The FDA is establishing a new active surveillance program in vaccine safety. ⺠We systematically developed a list of health outcomes of interest for this program. ⺠We gathered input from a variety of experts and to form an initial comprehensive list. ⺠A five-member expert panel and FDA selected 24 outcomes from this list. ⺠Next steps will include evidence reviews on computerized coding for these outcomes.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Tracy A. Lieu, Michael D. Nguyen, Robert Ball, David B. Martin,